Bacillus Calmette-Guérin vaccination and infant mortality
- PMID: 16608427
- DOI: 10.1586/14760584.5.2.277
Bacillus Calmette-Guérin vaccination and infant mortality
Abstract
When the bacillus Calmette-Guérin (BCG) vaccine was introduced in the 1920s, it was suggested that BCG occasionally had nonspecific beneficial effects on mortality beyond the specific protection against tuberculosis. Considering that BCG has since then become the most used vaccine in the world, surprisingly few studies have been undertaken into the effect of BCG on general mortality and morbidity. Recent studies suggest that BCG has beneficial nontargeted effects on general infant morbidity and mortality in low-income countries, often with the most pronounced effect among girls. These observational findings are supported by early trials in which children were randomized or alternated to BCG vaccination. Furthermore, a BCG scar and a positive tuberculin reaction are related to better survival among BCG-vaccinated children in low-income countries, especially for girls. The findings are not explained by frailty bias, in other words, that healthy children are more likely to receive BCG vaccination. A nonspecific, gender-differential effect of BCG on general infant mortality may have large implications for tuberculosis vaccine research and routine vaccination policy.
Similar articles
-
Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.Pediatr Infect Dis J. 2004 Jun;23(6):544-50. doi: 10.1097/01.inf.0000129693.81082.a0. Pediatr Infect Dis J. 2004. PMID: 15194836
-
Tuberculin reaction, BCG scar, and lower female mortality.Epidemiology. 2006 Sep;17(5):562-8. doi: 10.1097/01.ede.0000231546.14749.ab. Epidemiology. 2006. PMID: 16878042
-
Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines.Tuberculosis (Edinb). 2006 Nov;86(6):397-403. doi: 10.1016/j.tube.2006.02.001. Epub 2006 Aug 8. Tuberculosis (Edinb). 2006. PMID: 16901755 Review.
-
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?Vaccine. 2003 Jun 20;21(21-22):2782-90. doi: 10.1016/s0264-410x(03)00181-6. Vaccine. 2003. PMID: 12798618 Clinical Trial.
-
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.Health Technol Assess. 2013 Sep;17(37):1-372, v-vi. doi: 10.3310/hta17370. Health Technol Assess. 2013. PMID: 24021245 Free PMC article. Review.
Cited by
-
Nonspecific Effects of the Bacillus Calmette-Guérin Vaccine in Portuguese Children Under 5 Years of Age: Protocol for a Population-Based Historical Birth Cohort Study.JMIR Res Protoc. 2024 Mar 14;13:e55332. doi: 10.2196/55332. JMIR Res Protoc. 2024. PMID: 38328938 Free PMC article.
-
DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress.Cancers (Basel). 2022 Nov 29;14(23):5874. doi: 10.3390/cancers14235874. Cancers (Basel). 2022. PMID: 36497356 Free PMC article. Review.
-
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.Lancet Glob Health. 2022 Sep;10(9):e1307-e1316. doi: 10.1016/S2214-109X(22)00283-2. Lancet Glob Health. 2022. PMID: 35961354 Free PMC article.
-
Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019.BMC Infect Dis. 2022 Jun 23;22(1):569. doi: 10.1186/s12879-022-07547-4. BMC Infect Dis. 2022. PMID: 35739462 Free PMC article.
-
Recombinant BCG to Enhance Its Immunomodulatory Activities.Vaccines (Basel). 2022 May 23;10(5):827. doi: 10.3390/vaccines10050827. Vaccines (Basel). 2022. PMID: 35632582 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources